|
Structural rearrangement signatures as novel biomarkers for homologous recombination deficiency in cancer
|
Dana-Farber Cancer Institute |
Northwestern Mutual Foundation |
|
Investigating the Role of the MYCN Oncogene in Regulating Chemokine Expression in Neuroblastoma |
Children’s Hospital of Philadelphia |
Northwestern Mutual Foundation |
|
A Novel Adjunctive LAT-Activating CART (ALA-CART) Cell Platform for the Treatment of Acute Leukemia |
University of Colorado Denver_ Anschutz Medical Campus |
Northwestern Mutual Foundation |
|
Arginine Depletion with DFMO in High-Risk Neuroblastoma |
Children’s Hospital of Philadelphia |
Northwestern Mutual Foundation |
|
Synthetic Gene Expression Regulatory Switches (SynGERS) for Improved CAR T Cell Function in Pediatric Solid Tumors |
Baylor College of Medicine |
Northwestern Mutual Foundation |
|
Targeting the Checkpoint Receptor TIGIT via CRISPR/Cas9 Genome Editing to Enhance NK Cell Anti-Tumor Activity |
Research Institute at Nationwide Children's Hospital |
Northwestern Mutual Foundation |
|
Families of Children with Advanced Cancer: The Impact of Social Determinants of Health |
Research Institute at Nationwide Children's Hospital |
Northwestern Mutual Foundation |
|
DEFINING GENETIC DRIVER MUTATIONS,CLINIC CHARACTERISTICS & OUTCOMES IN CHILDREN & YOUNG ADULTS WITH HISTIOCYTOSES |
Baylor College of Medicine |
Northwestern Mutual Foundation |
|
L15/TGF-beta trap fusokine for treatment of pediatric sarcomas |
The Board of Regents of the University of Wisconsin System |
Northwestern Mutual Foundation |
|
Wilms tumor risk and management in WAGR Syndrome |
Children’s Hospital of Philadelphia |
Northwestern Mutual Foundation |